Disc Medicine, Inc.
IRON- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
內部人交易
每一列是一份 Form 4 申報裡同一種交易的合計。預設只顯示公開市場買進（P）與賣出（S）；要看公司授予、行使選擇權等其他代碼，請調整篩選條件。
| 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|
| 2022/4/13 | 2022/4/12 | Leonard Braden Michael持股 10% 以上大股東 | P買進Common Stock | +5.5 萬 | $1.37 | +$7.54 萬 | 27 萬 | +25.6% | SEC |
| 2022/4/13 | 2022/4/11–4/13 | Leonard Braden Michael持股 10% 以上大股東 | P買進Common Stock | +90 萬 | $1.4021 | +$126.19 萬 | 500 萬 | +22.0% | SEC |
| 2022/10/27 | 2022/10/26 | Leonard Braden Michael持股 10% 以上大股東 | S賣出Common Stock | −2.25 萬 | $2.09 | −$4.7 萬 | 24.75 萬 | −8.3% | SEC |
| 2023/2/17 | 2023/2/15 | Ashiya Mona董事、持股 10% 以上大股東 | P買進Common Stock | +10.87 萬 | $23.00 | +$250 萬 | 29.92 萬 | +57.1% | SEC |
| 2023/2/1716:42 ET | 2023/2/15 | Blavatnik Len 等 4 人持股 10% 以上大股東 | P買進Common Stock | +43.48 萬 | $23.00 | +$1,000 萬 | 314.18 萬 | +16.1% | SEC |
| 2023/2/1716:43 ET | 2023/2/15 | ORBIMED ADVISORS LLC 等 4 人董事、持股 10% 以上大股東 | P買進Common Stock | +10.87 萬 | $23.00 | +$250 萬 | 29.92 萬 | +57.1% | SEC |
| 2023/6/2016:01 ET | 2023/6/16 | Blavatnik Len 等 4 人持股 10% 以上大股東 | P買進Common Stock · 衍生 | +20.41 萬 | $48.9999 | +$999.99 萬 | 20.41 萬 | – | SEC |
| 2023/6/28 | 2023/6/28 | Novo Holdings A/S持股 10% 以上大股東 | S賣出Common Stock | −125 萬 | $46.10 | −$5,762.5 萬 | 109.08 萬 | −53.4% | SEC |
| 2023/6/30 | 2023/6/28 | Savage William Jacob醫療長 | S賣出Common Stock | −4,384 | $49.9795 | −$21.91 萬 | 1.59 萬 | −21.6% | SEC10b5-1 |
| 2023/6/30 | 2023/6/28 | Bryce Joanne財務長 | S賣出Common Stock | −1.01 萬 | $49.9532 | −$50.31 萬 | 1,260 | −88.9% | SEC10b5-1 |
| 2023/6/30 | 2023/6/28–6/30 | MacDonald Brian Richard創新長 | S賣出Common Stock | −1.45 萬 | $47.0288 | −$68.3 萬 | 1.29 萬 | −53.0% | SEC10b5-1 |
| 2023/6/30 | 2023/6/30 | MacDonald Brian Richard創新長 | S賣出Common Stock | +600 | $46.76 | +$2.81 萬 | 1.23 萬 | +5.1% | SEC10b5-1 |
| 2023/8/3 | 2023/8/1 | Bryce Joanne財務長 | S賣出Common Stock | −4,521 | $49.9098 | −$22.56 萬 | 1,260 | −78.2% | SEC10b5-1 |
| 2023/8/11 | 2023/8/9 | Savage William Jacob醫療長 | S賣出Common Stock | −8,269 | $49.8328 | −$41.21 萬 | 7,672 | −51.9% | SEC10b5-1 |
| 2023/8/16 | 2023/8/15 | Savage William Jacob醫療長 | S賣出Common Stock | −7,672 | $52.9493 | −$40.62 萬 | 0 | −100.0% | SEC10b5-1 |
| 2023/8/1618:55 ET | 2023/8/14–8/15 | Atlas Venture Fund X, L.P. 等 6 人持股 10% 以上大股東 | S賣出Common Stock | −28.61 萬 | $52.5175 | −$1,502.36 萬 | 195.12 萬 | −12.8% | SEC |
| 2023/8/1618:55 ET | 2023/8/15 | Atlas Venture Fund X, L.P. 等 6 人持股 10% 以上大股東 | S賣出Common Stock | −7.29 萬 | $52.40 | −$382.16 萬 | 88.22 萬 | −7.6% | SEC |
| 2023/8/17 | 2023/8/15 | Bitterman Kevin董事 | S賣出Common Stock | −7.29 萬 | $52.40 | −$382.16 萬 | 88.22 萬 | −7.6% | SEC |
| 2023/9/5 | 2023/9/1 | Bryce Joanne財務長 | S賣出Common Stock | −1,000 | $52.99 | −$5.3 萬 | 1,260 | −44.2% | SEC10b5-1 |
| 2023/9/1816:59 ET | 2023/9/14–9/16 | Atlas Venture Fund X, L.P. 等 3 人持股 10% 以上大股東 | S賣出Common Stock | −35.74 萬 | $53.1313 | −$1,899.17 萬 | 159.38 萬 | −18.3% | SEC |
| 2023/11/7 | 2023/11/3 | Khara Rahul法務長 | S賣出Common Stock | −100 | $50.00 | −$5,000 | 0 | −100.0% | SEC10b5-1 |
| 2023/11/15 | 2023/11/14 | Khara Rahul法務長 | S賣出Common Stock | −4,900 | $50.6135 | −$24.8 萬 | 0 | −100.0% | SEC10b5-1 |
| 2023/11/27 | 2023/11/22 | Khara Rahul法務長 | S賣出Common Stock | −1 萬 | $51.7359 | −$51.74 萬 | 0 | −100.0% | SEC10b5-1 |
| 2023/12/7 | 2023/12/5 | Bryce Joanne財務長 | S賣出Common Stock | −2,541 | $56.0008 | −$14.23 萬 | 2,500 | −50.4% | SEC10b5-1 |
| 2023/12/14 | 2023/12/12–12/14 | Ashiya Mona董事 | S賣出Common Stock | −13.42 萬 | $58.8842 | −$790.23 萬 | 72.78 萬 | −15.6% | SEC |
| 2023/12/14 | 2023/12/12 | Bryce Joanne財務長 | S賣出Common Stock | −2,500 | $65.22 | −$16.31 萬 | 2,500 | −50.0% | SEC10b5-1 |
| 2023/12/14 | 2023/12/12 | White William Richard董事 | S賣出Common Stock | −3.35 萬 | $63.2104 | −$211.82 萬 | 0 | −100.0% | SEC |
| 2023/12/14 | 2023/12/12–12/14 | Bitterman Kevin董事 | S賣出Common Stock | −7.61 萬 | $61.4451 | −$467.38 萬 | 80.62 萬 | −8.6% | SEC |
| 2023/12/1417:44 ET | 2023/12/12–12/14 | ORBIMED ADVISORS LLC 等 4 人董事 | S賣出Common Stock | −13.42 萬 | $58.8842 | −$790.23 萬 | 72.78 萬 | −15.6% | SEC |
| 2023/12/1420:13 ET | 2023/12/12–12/14 | Atlas Venture Fund X, L.P. 等 6 人持股 10% 以上大股東 | S賣出Common Stock | −11.41 萬 | $61.4451 | −$701.08 萬 | 147.97 萬 | −7.2% | SEC |
| 2023/12/1420:13 ET | 2023/12/12–12/14 | Atlas Venture Fund X, L.P. 等 6 人持股 10% 以上大股東 | S賣出Common Stock | −7.61 萬 | $61.4451 | −$467.38 萬 | 80.62 萬 | −8.6% | SEC |
| 2023/12/15 | 2023/12/14 | Ashiya Mona董事 | S賣出Common Stock | −43.32 萬 | $56.75 | −$2,458.41 萬 | 22.44 萬 | −65.9% | SEC |
| 2023/12/1518:04 ET | 2023/12/14 | ORBIMED ADVISORS LLC 等 4 人董事 | S賣出Common Stock | −43.32 萬 | $56.75 | −$2,458.41 萬 | 22.44 萬 | −65.9% | SEC |
| 2023/12/20 | 2023/12/18 | Ashiya Mona董事 | S賣出Common Stock | −1,724 | $59.24 | −$10.21 萬 | 0 | −100.0% | SEC |
| 2023/12/2018:28 ET | 2023/12/18 | ORBIMED ADVISORS LLC 等 4 人董事 | S賣出Common Stock | −1,724 | $59.24 | −$10.21 萬 | 0 | −100.0% | SEC |
| 2024/1/12 | 2024/1/10 | Bitterman Kevin董事 | S賣出Common Stock | −2 萬 | $64.00 | −$128 萬 | 78.62 萬 | −2.5% | SEC |
| 2024/1/1217:12 ET | 2024/1/10 | Atlas Venture Fund X, L.P. 等 6 人持股 10% 以上大股東 | S賣出Common Stock | −3 萬 | $64.00 | −$192 萬 | 144.97 萬 | −2.0% | SEC |
| 2024/1/1217:12 ET | 2024/1/10 | Atlas Venture Fund X, L.P. 等 6 人持股 10% 以上大股東 | S賣出Common Stock | −2 萬 | $64.00 | −$128 萬 | 78.62 萬 | −2.5% | SEC |
| 2024/1/25 | 2024/1/23 | Bitterman Kevin董事 | S賣出Common Stock | −10.25 萬 | $67.65 | −$693.41 萬 | 19.83 萬 | −34.1% | SEC |
| 2024/1/2516:31 ET | 2024/1/23 | Atlas Venture Fund X, L.P. 等 9 人持股 10% 以上大股東 | S賣出Common Stock | −4.75 萬 | $67.65 | −$321.34 萬 | 140.22 萬 | −3.3% | SEC |
| 2024/1/2516:31 ET | 2024/1/23 | Atlas Venture Fund X, L.P. 等 9 人持股 10% 以上大股東 | S賣出Common Stock | −10.25 萬 | $67.65 | −$693.41 萬 | 19.83 萬 | −34.1% | SEC |
| 2024/3/7 | 2024/3/5 | Bitterman Kevin董事 | S賣出Common Stock | −2.62 萬 | $73.50 | −$192.25 萬 | 67.75 萬 | −3.7% | SEC |
| 2024/4/15 | 2024/4/11 | White William Richard董事 | S賣出Common Stock | −2,560 | $31.8019 | −$8.14 萬 | 0 | −100.0% | SEC10b5-1 |
| 2024/5/3 | 2024/5/1 | White William Richard董事 | S賣出Common Stock | −201 | $28.6345 | −$5,755.53 | 0 | −100.0% | SEC10b5-1 |
| 2024/6/5 | 2024/6/3 | White William Richard董事 | S賣出Common Stock | −1,957 | $36.0782 | −$7.06 萬 | 0 | −100.0% | SEC10b5-1 |
| 2024/6/20 | 2024/6/17 | Ashiya Mona董事 | P買進Common Stock | +8.33 萬 | $36.00 | +$300 萬 | 23.54 萬 | +54.8% | SEC |
| 2024/6/20 | 2024/6/17 | Bitterman Kevin董事 | P買進Common Stock | +22.22 萬 | $36.00 | +$800 萬 | 42.05 萬 | +112.0% | SEC |
| 2024/6/2017:19 ET | 2024/6/17 | ORBIMED ADVISORS LLC 等 4 人董事 | P買進Common Stock | +8.33 萬 | $36.00 | +$300 萬 | 23.54 萬 | +54.8% | SEC |
| 2024/7/3 | 2024/7/1 | White William Richard董事 | S賣出Common Stock | −201 | $46.039 | −$9,253.84 | 0 | −100.0% | SEC10b5-1 |
| 2024/8/5 | 2024/8/1 | White William Richard董事 | S賣出Common Stock | −201 | $43.4413 | −$8,731.71 | 0 | −100.0% | SEC10b5-1 |